Scientists working at the Large Hadron Collider in Geneva may finally have tracked down the elusive Higgs boson. Results announced today at CERN show that a new heavy particle has been identified, with all the properties expected of the Higgs. Bristol physicists working at the CMS experiment played a key role in establishing this exciting new result which is the culmination of twenty years’ work.
Our genes control many aspects of who we are — from the colour of our hair to our vulnerability to certain diseases — but how are the genes, and consequently the proteins they make themselves controlled? Researchers have discovered a new group of molecules which control some of the fundamental processes behind memory function and may hold the key to developing new therapies for treating neurodegenerative diseases.
More than a quarter of the national Royal Academy of Engineering Leadership Advanced Awards have been awarded to students at the University of Bristol - putting the University top in the country once again.
A genetic test for an inherited disease in Burmese cats, called Burmese hypokalaemia, has been developed thanks to the identification of the genetic mutation responsible for the disease by a research team, including academics from the University of Bristol's School of Veterinary Sciences.
Jimena Lobo Guerrero Arenas, a postgraduate student in the Department of Archaeology and Anthropology, has been awarded a Short Term Research Grant from Harvard University for research into early colonial gold-working in Colombia.
Modern computer systems are becoming increasingly parallel, which can make them much more challenging to use efficiently.
Dr Katsu Goda, Lecturer in the Department of Civil Engineering at the University of Bristol, is to receive the 2012 Charles F. Richter Early Career Award, given by the Seismological Society of America (SSA).
The University of Bristol’s Quantum Photonics group have been awarded grants of over €3 million to solve the problem of sending information in single quantum particles over global distances.
A highly efficient method for making prostaglandins — natural, hormone-like chemicals that have pharmaceutical applications — is reported by University of Bristol scientists this week in Nature. Some synthetic analogues of prostaglandin are ‘billion dollar’ drugs; the prostaglandin analogue latanoprost, which is used to treat glaucoma and ocular hypertension, generates approximately $1.6 billion in sales each year.
Multicellularity in cyanobacteria originated before 2.4 billion years ago and is associated with the accumulation of atmospheric oxygen, subsequently enabling the evolution of aerobic life, as we know it today, according to a new study from the University of Zurich involving researchers now at the University of Bristol, and Gothenburg.
